Kidney damage associated with COVID-19: from the acute to the chronic phase

References

• Lopes-Pacheco M, Silva PL, Cruz FF, et al. Pathogenesis of multiple organ injury in COVID-19 and potential therapeutic strategies. Front Physiol. 2021;12:1. doi:10.3389/fphys.2021.593223.
   Web of Science ®Google Scholar
• Nlandu Y, Makulo JR, Essig M, et al. Factors associated with acute kidney injury (AKI) and mortality in COVID-19 patients in a Sub-Saharan african intensive care unit: a single-center prospective study. Ren Fail. 2023;45(2):2263583.
   PubMed Web of Science ®Google Scholar
• Nlandu YM, Sakaji TJM, Engole YM, et al. Frequency and factors associated with proteinuria in COVID-19 patients: a cross-sectional study. Pan Afr Med J. 2021;40:37. doi:10.11604/pamj.2021.40.37.29796.
   PubMed Web of Science ®Google Scholar
• May RM, Cassol C, Hannoudi A, et al. A multi-center retrospective cohort study defines the spectrum of kidney pathology in coronavirus 2019 disease (COVID-19). Kidney Int. 2021;100(6):1303–9. doi:10.1016/j.kint.2021.07.015.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829–838. doi:10.1016/j.kint.2020.03.005.
   PubMed Web of Science ®Google Scholar
• Fiorentino M, Grandaliano G, Gesualdo L, et al. Acute kidney injury to chronic kidney disease transition. Contrib Nephrol. 2018;193:45–54. doi:10.1159/000484962.
   PubMed Web of Science ®Google Scholar
• Davis HE, McCorkell L, Vogel JM, et al. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133–146. doi:10.1038/s41579-022-00846-2.
   PubMed Web of Science ®Google Scholar
• Chawla LS, Bellomo R, Bihorac A, et al. Acute kidney disease and renal recovery: consensus report of the acute disease quality initiative (ADQI) 16 workgroup. Nat Rev Nephrol. 2017;13(4):241–257. doi:10.1038/nrneph.2017.2.
   PubMed Web of Science ®Google Scholar
• Egbi OG, Adejumo OA, Akinbodewa AA. Coronavirus infection and kidney disease: a review of current and emerging evidence. Pan Afr Med J. 2020;37:149. doi:10.11604/pamj.2020.37.149.23655.
   PubMed Web of Science ®Google Scholar
• Levin A, Stevens PE, Bilous RW, et al. Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1–150.
   Web of Science ®Google Scholar
• Lin L, Wang X, Ren J, et al. Risk factors and prognosis for COVID-19-induced acute kidney injury: a meta-analysis. BMJ Open. 2020;10(11):e042573. doi:10.1136/bmjopen-2020-042573.
   PubMed Web of Science ®Google Scholar
• Xu Z, Tang Y, Huang Q, et al. Systematic review and subgroup analysis of the incidence of acute kidney injury (AKI) in patients with COVID-19. BMC Nephrol. 2021;22(1):52. doi:10.1186/s12882-021-02244-x.
   PubMed Web of Science ®Google Scholar
• Mohamed MMB, Lukitsch I, Torres-Ortiz AE, et al. Acute kidney injury associated with coronavirus disease 2019 in urban new orleans. Kidney360. 2020;1(7):614–622. doi:10.34067/KID.0002652020.
   PubMedGoogle Scholar
• Robbins-Juarez SY, Qian L, King KL, et al. Outcomes for patients with COVID-19 and acute kidney injury: a systematic review and Meta-Analysis. Kidney Int Rep. 2020;5(8):1149–1160. doi:10.1016/j.ekir.2020.06.013.
   PubMed Web of Science ®Google Scholar
• Neves PDMdM, Sato VAH, Mohrbacher S, et al. Acute kidney injury due to COVID-19 in intensive care unit: an analysis from a Latin-American center. Front Med (Lausanne). 2021;8:620050. doi:10.3389/fmed.2021.620050.
   PubMed Web of Science ®Google Scholar
• Tannor EK, Ofori E, Hutton-Mensah KA, et al. Acute kidney injury and in-hospital mortality among patients with COVID-19 in Ghana – a single Centre study. Afr J Nephrol. 2023;26(1):38–46.
   Google Scholar
• Goffe TK, Alemu ZA, Niguss Derese T, et al. Acute kidney injury among admitted COVID-19 patients in Addis Ababa, Ethiopia. Int J Nephrol Renovasc Dis. 2023;16:83–92. doi:10.2147/IJNRD.S402946.
   PubMed Web of Science ®Google Scholar
• Bashir AM, Mukhtar MS, Mohamed YG, et al. Prevalence of acute kidney injury in covid-19 patients- retrospective Single-Center study. Infect Drug Resist. 2022;15:1555–1560. doi:10.2147/IDR.S357997.
   PubMed Web of Science ®Google Scholar
• Zhang J, Pang Q, Zhou T, et al. Risk factors for acute kidney injury in COVID-19 patients: an updated systematic review and meta-analysis. Ren Fail. 2023;45(1):2170809.
   PubMed Web of Science ®Google Scholar
• Wainstein M, Spyrison N, Dai D, et al. Association of country income level with the characteristics and outcomes of critically ill patients hospitalized with acute kidney injury and COVID-19. Kidney Int Rep. 2023;8(8):1514–1530. doi:10.1016/j.ekir.2023.05.015.
   PubMed Web of Science ®Google Scholar
• Hung AM, Shah SC, Bick AG, et al. APOL1 risk variants, acute kidney injury, and death in participants with african ancestry hospitalized with COVID-19 from the million veteran program. JAMA Intern Med. 2022;182(4):386–395. doi:10.1001/jamainternmed.2021.8538.
   PubMed Web of Science ®Google Scholar
• Chan L, Chaudhary K, Saha A, et al. AKI in hospitalized patients with COVID-19. J Am Soc Nephrol. 2021;32(1):151–160. doi:10.1681/ASN.2020050615.
   PubMed Web of Science ®Google Scholar
• La Rosa R, Grechi B, Ragazzi R, et al. Incidence and determinants of acute kidney injury after prone positioning in severe COVID-19 acute respiratory distress syndrome. Healthc Basel Switz. 2023;11(21):2903. doi:10.3390/healthcare11212903.
   PubMedGoogle Scholar
• Wintjens MSJN, van Rosmalen F, Hemmelder MH, et al. Prone positioning is followed by a transient decrease in glomerular filtration rate: the prospective maastricht intensive care COVID cohort. J Nephrol. 2023;36(9):2669–2671. doi:10.1007/s40620-023-01767-w.
   PubMed Web of Science ®Google Scholar
• Sánchez ADLV, Pérez AN, Pérez-Carrasco M, et al. Acute kidney injury in critically ill patients with COVID-19: the AKICOV multicenter study in Catalonia. PLoS One. 2023;18(4):e0284248. doi:10.1371/journal.pone.0284248.
   PubMed Web of Science ®Google Scholar
• Jana KR, Yap E, Janga KC, et al. Comparison of two waves of COVID-19 in critically ill patients: a retrospective observational study. Int J Nephrol. 2022;2022:3773625–3773626. doi:10.1155/2022/3773625.
   PubMed Web of Science ®Google Scholar
• Lumlertgul N, Pirondini L, Cooney E, et al. Acute kidney injury prevalence, progression and long-term outcomes in critically ill patients with COVID-19: a cohort study. Ann Intensive Care. 2021;11(1):123. doi:10.1186/s13613-021-00914-5.
   PubMed Web of Science ®Google Scholar
• Martínez-Baz I, Miqueleiz A, Egüés N, et al. Effect of COVID-19 vaccination on the SARS-CoV-2 transmission among social and household close contacts: a cohort study. J Infect Public Health. 2023;16(3):410–417. doi:10.1016/j.jiph.2023.01.017.
   PubMed Web of Science ®Google Scholar
• Bobot M, Tonon D, Peres N, et al. Impact of dexamethasone and inhaled nitric oxide on severe acute kidney injury in critically ill patients with COVID-19. J Clin Med. 2022;11(20):6130. doi:10.3390/jcm11206130.
   PubMed Web of Science ®Google Scholar
• Kolhe NV, Fluck RJ, Selby NM, et al. Acute kidney injury associated with COVID-19: a retrospective cohort study. Remuzzi G, éditeur. PLoS Med. 2020;17(10):e1003406. doi:10.1371/journal.pmed.1003406.
   PubMed Web of Science ®Google Scholar
• Diebold M, Zimmermann T, Dickenmann M, et al. Comparison of acute kidney injury in patients with COVID-19 and other respiratory infections: a prospective cohort study. J Clin Med. 2021;10(11):2288. doi:10.3390/jcm10112288.
   PubMed Web of Science ®Google Scholar
• Nlandu Y, Mafuta D, Sakaji J, et al. Predictors of mortality in COVID-19 patients at kinshasa medical center and a survival analysis: a retrospective cohort study. BMC Infect Dis. 2021;21(1):1272. doi:10.1186/s12879-021-06984-x.
   PubMed Web of Science ®Google Scholar
• Zahid U, Ramachandran P, Spitalewitz S, et al. Acute kidney injury in COVID-19 patients: an inner city hospital experience and policy implications. Am J Nephrol. 2020;51(10):786–796. doi:10.1159/000511160.
   PubMed Web of Science ®Google Scholar
• Su L, Zhang J, Peng Z. The role of kidney injury biomarkers in COVID-19. Ren Fail. 1280;‑44(1):1280–1288.
   PubMedGoogle Scholar
• Larcher R, Bargnoux AS, Badiou S, et al. Acute kidney injury in critical COVID-19 patients: usefulness of urinary biomarkers and kidney proximal tubulopathy. Ren Fail. 2023;45(2):2292152.
   PubMed Web of Science ®Google Scholar
• Werion A, Belkhir L, Perrot M, et al. SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule. Kidney Int. 2020;98(5):1296–1307. doi:10.1016/j.kint.2020.07.019.
   PubMed Web of Science ®Google Scholar
• Su H, Yang M, Wan C, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020;98(1):219–227. doi:10.1016/j.kint.2020.04.003.
   PubMed Web of Science ®Google Scholar
• Couturier A, Ferlicot S, Chevalier K, et al. Indirect effects of severe acute respiratory syndrome coronavirus 2 on the kidney in coronavirus disease patients. Clin Kidney J. 2020;13(3):347–353. doi:10.1093/ckj/sfaa088.
   PubMed Web of Science ®Google Scholar
• Akilesh S, Nast CC, Yamashita M, et al. Multicenter clinicopathologic correlation of kidney biopsies performed in COVID-19 patients presenting with acute kidney injury or proteinuria. Am J Kidney Dis. 2021;77(1):82–93.e1. e1. doi:10.1053/j.ajkd.2020.10.001.
   PubMed Web of Science ®Google Scholar
• Silva AVBD, Campanati JDaG, Barcelos IDS, et al. COVID-19 and acute kidney injury ― direct and indirect pathophysiological mechanisms underlying lesion development. An Acad Bras Cienc. 2022;94(suppl 3):e20211501. doi:10.1590/0001-3765202220211501.
   PubMedGoogle Scholar
• Hafez W. COVID-19 patient characteristics and time to viral clearance: a retrospective observational study in a multiethnic population (United Arab Emirates). J Clin Virol. 2022;157:105297. doi:10.1016/j.jcv.2022.105297.
   PubMed Web of Science ®Google Scholar
• Armaly Z, Kinaneh S, Skorecki K. Renal manifestations of covid-19: physiology and pathophysiology. J Clin Med. 2021;10(6):1216. doi:10.3390/jcm10061216.
   PubMed Web of Science ®Google Scholar
• See YP, Young BE, Ang LW, et al. Risk factors for development of acute kidney injury in COVID-19 patients: a retrospective observational cohort study. Nephron. 2021;145(3):256–264. doi:10.1159/000514064.
   PubMed Web of Science ®Google Scholar
• Chaudhri I, Moffitt R, Taub E, et al. Association of proteinuria and hematuria with acute kidney injury and mortality in hospitalized patients with COVID-19. Kidney Blood Press Res. 2020;45(6):1018–1032. doi:10.1159/000511946.
   PubMed Web of Science ®Google Scholar
• Fisher M, Neugarten J, Bellin E, et al. AKI in hospitalized patients with and without COVID-19: a comparison study. J Am Soc Nephrol. 2020;31(9):2145–2157. doi:10.1681/ASN.2020040509.
   PubMed Web of Science ®Google Scholar
• Bouquegneau A, Huart J, Lutteri L, et al. Survivors of COVID-19 mostly recover from tubular proteinuria and acute kidney injury after hospital discharge. J Nephrol. 2021;34(4):967–969. doi:10.1007/s40620-021-01075-1.
   PubMed Web of Science ®Google Scholar
• Pei G, Zhang Z, Peng J, et al. Renal involvement and early prognosis in patients with COVID-19 pneumonia. J Am Soc Nephrol. 2020;31(6):1157–1165. doi:10.1681/ASN.2020030276.
   PubMed Web of Science ®Google Scholar
• Angel-Korman A, Leiba A. Urinary findings reveal dominant tubular injury in hospitalized patients with COVID-19. J Am Soc Nephrol. 2021;32:67–68.
   Google Scholar
• Huart J, Bouquegneau A, Lutteri L, et al. Proteinuria in COVID-19: prevalence, characterization and prognostic role. J Nephrol. 2021;34(2):355–364. doi:10.1007/s40620-020-00931-w.
   PubMed Web of Science ®Google Scholar
• Meijers B, Hilbrands LB. The clinical characteristics of coronavirus-associated nephropathy. Nephrol Dial Transplant. 2020;35(8):1279–1281. doi:10.1093/ndt/gfaa197.
   PubMed Web of Science ®Google Scholar
• D’Amico G, Bazzi C. Pathophysiology of proteinuria. Kidney Int. 2003;63(3):809–825. doi:10.1046/j.1523-1755.2003.00840.x.
   PubMed Web of Science ®Google Scholar
• Mohamed MMB, Velez JCQ. Proteinuria in COVID-19. Clin Kidney J. 2021;14(Suppl 1):i40–i47. doi:10.1093/ckj/sfab036.
   PubMedGoogle Scholar
• Gross O, Moerer O, Weber M, et al. COVID-19-associated nephritis: early warning for disease severity and complications? Lancet. 2020;395(10236):e87–e88. doi:10.1016/S0140-6736(20)31041-2.
   PubMed Web of Science ®Google Scholar
• Lely AT, Hamming I, van Goor H, et al. Renal ACE2 expression in human kidney disease. J Pathol. 2004;204(5):587–593. doi:10.1002/path.1670.
   PubMed Web of Science ®Google Scholar
• Morelle J, Alexis W, Belkhir L, et al. L’infection à SARS-CoV-2 cause une dysfonction tubulaire proximale du rein. Louvain Médical. 2020;139(8):496–499. [Mismatch In:
   Google Scholar
• Kormann R, Jacquot A, Alla A, et al. Coronavirus disease 2019: acute fanconi syndrome precedes acute kidney injury. Clin Kidney J. 2020;13(3):362–370.
   PubMed Web of Science ®Google Scholar
• Liu L, He F, Cai SS, et al. Clinical characteristics of hospitalized patients with 2019 novel coronavirus disease indicate potential proximal tubular dysfunction. Chin Med J (Engl). 2020;133(16):1983–1985. doi:10.1097/CM9.0000000000000945.
   PubMed Web of Science ®Google Scholar
• Frelih M, Erman A, Wechtersbach K, et al. SARS-CoV-2 virions or ubiquitous cell structures? Actual dilemma in COVID-19 era. Kidney Int Rep. 2020;5(9):1608–1610. doi:10.1016/j.ekir.2020.07.003.
   PubMed Web of Science ®Google Scholar
• Wongboonsin J, Shah SI, Marty FM, et al. Osmotic tubulopathy in a patient with COVID-19 treated with remdesivir. Kidney Int Rep. 2021;6(7):1987–1991. doi:10.1016/j.ekir.2021.04.032.
   PubMed Web of Science ®Google Scholar
• Wan ER, Woolfson RG, Greenwood R, et al. Transient renal tubular syndromes associated with acute COVID-19 disease. Kidney Int Rep. 2020;5(9):1610–1611. doi:10.1016/j.ekir.2020.06.037.
   PubMed Web of Science ®Google Scholar
• Nlandu YM, Engole YM, Mboliassa MFI, et al. Ineffectiveness of intermittent hemodialysis in a critically ill COVID-19 patient: a case of persistent Heparin-Induced hyperkalemia. Case Rep Nephrol. 2022;2022:8613656. doi:10.1155/2022/8613656.
   PubMedGoogle Scholar
• Abdulaziz S, Beshir SE, Kuhail A, et al. Renal tubular acidosis in critically ill patients with coronavirus disease 2019 acute respiratory distress syndrome. Saudi J Kidney Dis Transpl. 2021;32(3):869–874. doi:10.4103/1319-2442.336786.
   PubMed Web of Science ®Google Scholar
• Bowe B, Xie Y, Xu E, et al. Kidney outcomes in long COVID. J Am Soc Nephrol. 2021;32(11):2851–2862. doi:10.1681/ASN.2021060734.
   PubMed Web of Science ®Google Scholar
• Nugent J, Aklilu A, Yamamoto Y, et al. Assessment of acute kidney injury and longitudinal kidney function after hospital discharge among patients with and without COVID-19. JAMA Netw Open. 2021;4(3):e211095. doi:10.1001/jamanetworkopen.2021.1095.
   PubMed Web of Science ®Google Scholar
• Volbeda M, Jou-Valencia D, van den Heuvel MC, et al. Acute and chronic histopathological findings in renal biopsies in COVID-19. Clin Exp Med. 2023;23(4):1003–1014. doi:10.1007/s10238-022-00941-x.
   PubMed Web of Science ®Google Scholar
• Nasr SH, Alexander MP, Cornell LD, et al. Kidney biopsy findings in patients with COVID-19, kidney injury, and proteinuria. Am J Kidney Dis. 2021;77(3):465–468. doi:10.1053/j.ajkd.2020.11.002.
   PubMed Web of Science ®Google Scholar
• Lai Y, Liu X, Wu Y, et al. Interstitial fibrosis and tubular atrophy measurement via hierarchical extractions of kidney and atrophy regions with deep learning method. Measurement. 2022;202:111885. doi:10.1016/j.measurement.2022.111885.
   Web of Science ®Google Scholar
• Farris AB, Colvin RB. Renal interstitial fibrosis: mechanisms and evaluation In. Curr Opin Nephrol Hypertens. 2012;21(3):289–300. doi:10.1097/MNH.0b013e3283521cfa.
   PubMed Web of Science ®Google Scholar
• Jansen J, Reimer KC, Nagai JS, et al. SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids. Cell Stem Cell. 2022;29(2):217–231.e8. doi: 10.1016/j.stem.2021.12.010.
   PubMed Web of Science ®Google Scholar
• Schmidt-Lauber C, Hänzelmann S, Schunk S, et al. Kidney outcome after mild to moderate COVID-19. Nephrol Dial Transplant. 2023;38(9):2031–2040. doi:10.1093/ndt/gfad008.
   PubMed Web of Science ®Google Scholar
• Cutrim ÉMM, Neves PDMM, Campos MAG, et al. Collapsing glomerulopathy: a review by the collapsing Brazilian consortium. Front Med. 2022;9:846173. doi:10.3389/fmed.2022.846173.
   Web of Science ®Google Scholar
• Kudose S, Santoriello D, Bomback AS, et al. Longitudinal outcomes of COVID-19–associated collapsing glomerulopathy and other podocytopathies. J Am Soc Nephrol. 2021;32(11):2958–2969. doi:10.1681/ASN.2021070931.
   PubMed Web of Science ®Google Scholar
• Giannini G, Carlos Q Velez J, May RM, et al. Renal prognosis of COVID-19 associated nephropathy. Kidney Int Rep. 2022;7(12):2722–2725. doi:10.1016/j.ekir.2022.09.027.
   PubMed Web of Science ®Google Scholar
• Mihai S, Codrici E, Popescu ID, et al. Inflammation-Related mechanisms in chronic kidney disease prediction, progression, and outcome. J Immunol Res. 2018;2018[cité 17 janv 2024];2018. Disponible sur: :2180373–2180316. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6146775/ doi:10.1155/2018/2180373.
   PubMed Web of Science ®Google Scholar
• Maamar M, Artime A, Pariente E, et al. Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: a cross-sectional study. Curr Med Res Opin. 2022;38(6):901–909. doi:10.1080/03007995.2022.2042991.
   PubMed Web of Science ®Google Scholar
• Klimova EM, Bozhkov AI, Lavinska OV, et al. Low molecular weight cytotoxic components (DAMPs) form the post-COVID-19 syndrome. Immunobiology. 2023;228(1):152316. doi:10.1016/j.imbio.2022.152316.
   PubMed Web of Science ®Google Scholar
• Zhang JY, Whalley JP, Knight JC, et al. SARS-CoV-2 infection induces a long-lived pro-inflammatory transcriptional profile. Genome Med. 2023;15(1):69. doi:10.1186/s13073-023-01227-x.
   PubMed Web of Science ®Google Scholar
• Gameil MA, Marzouk RE, Elsebaie AH, et al. Long-term clinical and biochemical residue after COVID-19 recovery. Egypt Liver J. 2021;11(1):74.
   PubMedGoogle Scholar
• Doykov I, Hällqvist J, Gilmour KC, et al. « The long tail of covid-19 » - the detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Res. 2020;9:1349. doi:10.12688/f1000research.27287.1.
   PubMedGoogle Scholar
• Stuveling EM, Hillege HL, Bakker SJL, et al. C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int. 2003;63(2):654–661. doi:10.1046/j.1523-1755.2003.00762.x.
   PubMed Web of Science ®Google Scholar
• Kochi M, Kohagura K, Shiohira Y, et al. Inflammation as a risk of developing chronic kidney disease in rheumatoid arthritis. PLoS One. 2016;11(8):e0160225. doi:10.1371/journal.pone.0160225.
   PubMed Web of Science ®Google Scholar
• Bento GAO, Leite VLT, Campos RP, et al. Reduction of estimated glomerular filtration rate after COVID-19-associated acute kidney injury. Braz J Nephrol. 2023;45(4):488–494. doi:10.1590/2175-8239-jbn-2022-0179pt.
   Google Scholar
• Huang R, Fu P, Ma L. Kidney fibrosis: from mechanisms to therapeutic medicines. Signal Transduct Target Ther. 2023;8(1):1–20.
   PubMed Web of Science ®Google Scholar